Asymptomatic atrial fibrillation on device interrogation

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 8, 2008, Pages 891-893

  Lim, Hoong Sern ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; VON WILLEBRAND FACTOR;

ANTICOAGULANT THERAPY; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATOR; DIABETES MELLITUS; ELECTROCARDIOGRAM; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HUMAN; HYPERTENSION; PACEMAKER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; TACHYCARDIA; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS;

EID: 45149131483     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01194.x     Document Type: Review

References (36)

1. Saksena S, Hettrick DA, Koehler JL, et al : Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J 2007 154 : 884 892.
2. Atrial Fibrillation Investigators : Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from 5 randomized controlled trials. Arch Intern Med 1994 154 : 1449 1457.
3. Albers GW, Dalen JE, Laupacis A, et al : Antithrombotic therapy in atrial fibrillation. Chest 2001 119 : 1945 1965.
4. Psaty BM, Manolio TA, Kuller LH, et al : Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997 96 : 2455 2461.
5. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM : Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994 74 : 236 241.
6. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ : Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. Ann Intern Med 1996 124 : 16 20.
7. Roche F, Gaspoz JM, Da Costa A, et al : Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol 2002 25 : 1587 1593.
8. Fetsch T, Bauer P, Engberding R, et al : Prevention of atrial fibrillation after cardioversion: Results of the PAFAC trial Eur. Heart J 2004 25 : 1385 1394.
9. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL : Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994 89 : 224 227.
10. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL : Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or silent atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation 2003 107 : 1141 1145.
11. Liao J, Khalid Z, Scallan C, et al : Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischaemic stroke: A systematic review. Stroke 2007 38 : 2935 2940.
12. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators : A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.
13. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH : Long-term risk of recurrent atrial fibrillation as documented by implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004 43 : 47 52.
14. Orlov MV, Ghali JK, Araghi-Niknam M, et al : for the Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: Incidence, progression and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol 2007 30 : 404 411.
15. Pollak WM, Simmons JD, Interian A, et al : Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001 24 : 424 429.
16. Seidl K, Meisel E, Van Agt E, et al : Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? Pacing Clin Electrophysiol 1998 21 : 694 700.
17. Fitts SM, Hill MR, Mehra R, Gillis AM : High rate atrial tachyarrhythmia detections in implantable pulse generators: Low incidence of false-positive detections. Pacing Clin Electrophysiol 2000 23 : 1080 1086.
18. Passman RS, Weinberg KM, Freher M, et al : Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004 15 : 773 777.
19. De Voogt WG, van Hemel NM, van de Bos AA, et al : Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording. Europace 2006 8 : 950 961.
20. Morris JJ, Kong Y, North WC, McIntosh HD : Experience with 'cardioversion' of atrial fibrillation and flutter. Am J Cardiol 1964 14 : 94 100.
21. Bjerkelund C, Orning OM : The efficacy of anticoagulant therapy in preventing embolism related to D. C. electrical conversion of atrial fibrillation. Am J Cardiol 1969 23 : 208 216.
22. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG : Role of prophylactic anticoagulation for direct cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992 19 : 851 855.
23. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ : Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation of less than 48 hours' duration. Ann Intern Med 1997 126 : 615 620.
24. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ : Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : S429 S456.
25. Glotzer TV, Hellkamp AS, Zimmerman J, et al : Atrial high rate episodes detected by pacemaker diagnostics predicts death and stroke: Report of the atrial diagnostic ancillary study of the Mode Selection Trial (MOST). Circulation 2003 107 : 1614 1619.
26. Capucci A, Santini M, Padeletti L, Gulizia M, Botto GL, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico M : Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005 46 : 1913 1192.
27. Kortz RAM, Delemarre BJ, van Dantzig JM, et al : Left atrial appendage blood flow determined by transesophageal echocardiography in healthy subjects. Am J Cardiol 1993 71 : 976 981.
28. Bilge M, Eryonucu B, Güler N, et al : Transesophageal echocardiography assessment of left atrial appendage function in untreated systemic hypertensive patients in sinus rhythm. J Am Soc Echocardiogr 2000 13 271 276.
29. Fukuchi M, Watanabe J, Kumagai K, et al : Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001 37 : 1436 1442.
30. Kapur NK, Deming CB, Kapur S, et al : Haemodynamic modulation of endocardial thromboresistance. Circulation 2007 115 : 67 75.
31. Lip GY, Gibbs CR : Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999 33 : 1424 1426.
32. Nadar S, Lip GY : The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Des 2003 9 : 1715 1732.
33. Lim HS, MacFadyen RJ, Bakris G, Lip GY : The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: Implications for hypertension management. Curr Pharm Des 2006 12 : 1567 1579.
34. Feng D, D'Agostino RB, Silbershatz H, Lipinska I, Massaro J, Levy D, Benjamin EJ, Wolf PA, Tofler GH : Hemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol 2001 87 : 168 171.
35. Lip GY, Blann AD : Atrial fibrillation and abnormalities of hemostatic factors. Am J Cardiol 2001 87 : 1136 1137.
36. Lip GY, Lim HS : Atrial fibrillation and stroke prevention. Lancet Neurol 2007 6 : 981 993.